Page last updated: 2024-12-10

oxytocin, phe(2)-orn(8)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxytocin, Phe(2)-Orn(8)-: RN given refers to all (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3081982
SCHEMBL ID15512342
MeSH IDM0136102

Synonyms (10)

Synonym
oxytocin, phe(2)-orn(8)-
oxytocin, phenylalanyl(2)-ornithine(8)-
oxytocin, 2-l-phenylalanine-8-l-ornithine-
poot
2-phe-8-orn-oxytocin
pi ornipressin
(2s)-n-[(2s)-4-amino-1-[[(2r)-1-[(2s)-2-[[(2s)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]-2-[[(2s,3s)-2-[[(2s)-2-[[(2r)-2-amino-3-sulfanylidenepropanoyl]amino]-
2480-41-3
SCHEMBL15512342
DTXSID20179500
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (38.89)18.7374
1990's7 (38.89)18.2507
2000's3 (16.67)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]